Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Click here for the RSS feed for Publications IMB Publications RSS Feed

Publications

Below you will find a list of all IMB Publications. You can filter this list by choosing from the tags on the left and you can select multiple tags if you wish. Before commencing a new search, please ensure you remove any tags/filters you have previously applied by clicking Remove Filters.

You can also search all Publications by entering a keyword(s) in the search box and clicking the Search link.

Search:  Search

Page 1 of 7
Date Title
04/01/2010 Field Safety Notice Monthly Summary Sheet - January 2010
08/01/2010 Application for variation to a marketing authorisation
08/01/2010 Application for Variation to a Marketing Authorisation
25/01/2010 New Publication by Health and Social Care Regulatory Forum
26/01/2010 Reductil (sibutramine) - Important Safety Information from Abbott Laboratories Ireland Ltd. as approved by the Irish Medicines Board
29/01/2010 Bisphosphonates and Osteonecrosis of the Jaw: Risk Minimisation and Recommended Preventative Dental Measures
04/02/2010 RAPAMUNE® (sirolimus) - Important Safety Information from Wyeth Pharmaceuticals Limited as approved by the Irish Medicines Board
07/02/2010 Bisphosphonates and Osteonecrosis of the jaw: update on risk minimisation including new recommendations on preventative dental measures
08/02/2010 Annual Report 2008
09/02/2010 Drug Safety Newsletter - 35th Edition
09/02/2010 IMB Newsletter Issue No. 34 September - December 2009
11/02/2010 Ivermectin products with amended withdrawal periods
15/02/2010 Publication of Field Safety Notices
16/02/2010 Protopic - Important Safety Information from Astellas Pharma Co. Ltd. as approved by the Irish Medicines Board
18/02/2010 Notification of Withdrawal of Authorisations or Certificates for Human Medicines: Application Form
22/02/2010 An update on the association of natalizumab (TYSABRI) with Progressive Multifocal Leukoencephalopathy (PML) - Important Safety Information from Elan and Biogen Idec (Ireland) Limited as approved by the Irish Medicines Board
26/02/2010 Avoiding Medication Errors with Perindopril Arginine/Amlodipine (Acerycal) Combination Products
02/03/2010 Fabrazyme (agalsidase beta) - Important Safety Information from Genzyme as approved by the Irish Medicines Board
02/03/2010 Cerezyme (imiglucerase) - Important Safety Information from Genzyme as approved by the Irish Medicines Board
02/03/2010 Field Safety Notice Monthly Summary Sheet - February 2010
Page 1 of 7



Date Printed: 21 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971